Cardiomyopathies, Primary
|
0.010 |
Biomarker
|
group |
BEFREE |
PRL-3, a protein tyrosine phosphatase, was identified in a cDNA library from an explanted human heart obtained from a patient with idiopathic cardiomyopathy.
|
11355880 |
2001 |
tumor vasculature
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
PRL-3 is also expressed in tumor vasculature, regardless of the tumor source.
|
14654542 |
2003 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
PRL-3 is also expressed in tumor vasculature, regardless of the tumor source.
|
14654542 |
2003 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 mRNA expression was elevated in nearly all metastatic lesions derived from CRCs, regardless of the site of metastasis (liver, lung, brain, or ovary).
|
14654542 |
2003 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
PRL-3 mRNA expression was elevated in nearly all metastatic lesions derived from CRCs, regardless of the site of metastasis (liver, lung, brain, or ovary).
|
14654542 |
2003 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
PRL-3 mRNA levels were determined in several normal human endothelial cells exposed or unexposed to the phorbol ester phorbol 12-myristate 13-acetate (PMA) and in 27 human tumor cell lines.
|
16505094 |
2006 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
PRL-3 is amplified and its message is up-regulated in colorectal carcinoma metastases.
|
16540666 |
2006 |
Secondary Neoplasm
|
0.070 |
AlteredExpression
|
group |
BEFREE |
PRL-3 is amplified and its message is up-regulated in colorectal carcinoma metastases.
|
16540666 |
2006 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
|
17192274 |
2007 |
Malignant neoplasm of stomach
|
0.100 |
Biomarker
|
disease |
BEFREE |
PRL-3 might be a novel molecular marker for aggressive gastric cancer.
|
17235563 |
2007 |
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
PRL-3 might be a novel molecular marker for aggressive gastric cancer.
|
17235563 |
2007 |
Malignant neoplasm of stomach
|
0.100 |
Biomarker
|
disease |
BEFREE |
PRL-3 plays a key role in the control of gastric cancer growth.
|
19009246 |
2009 |
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
PRL-3 plays a key role in the control of gastric cancer growth.
|
19009246 |
2009 |
Non-Small Cell Lung Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 expression in NSCLC was high, and this over-expression is correlated with advanced clinical stage (p = 0.019), distant metastasis (p = 0.001), lymph node metastasis (p = 0.001), and poor post-operative survival.
|
19152186 |
2009 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
PRL-3 expression in NSCLC was high, and this over-expression is correlated with advanced clinical stage (p = 0.019), distant metastasis (p = 0.001), lymph node metastasis (p = 0.001), and poor post-operative survival.
|
19152186 |
2009 |
Malignant neoplasm of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 induces microvascular and lymphatic vessel formation by facilitating VEGF and VEGF-C expression in lung cancer tissues, thus promoting distant and lymph node metastasis of lung cancer.
|
19152186 |
2009 |
Carcinoma of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 induces microvascular and lymphatic vessel formation by facilitating VEGF and VEGF-C expression in lung cancer tissues, thus promoting distant and lymph node metastasis of lung cancer.
|
19152186 |
2009 |
Primary malignant neoplasm of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 induces microvascular and lymphatic vessel formation by facilitating VEGF and VEGF-C expression in lung cancer tissues, thus promoting distant and lymph node metastasis of lung cancer.
|
19152186 |
2009 |
Secondary malignant neoplasm of lymph node
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 induces microvascular and lymphatic vessel formation by facilitating VEGF and VEGF-C expression in lung cancer tissues, thus promoting distant and lymph node metastasis of lung cancer.
|
19152186 |
2009 |
Malignant neoplasm of stomach
|
0.100 |
Biomarker
|
disease |
BEFREE |
PRL-3 plays a key role in the growth of gastric cancer.
|
19187591 |
2008 |
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
PRL-3 plays a key role in the growth of gastric cancer.
|
19187591 |
2008 |
Malignant tumor of colon
|
0.040 |
Biomarker
|
disease |
BEFREE |
PRL-3 may predict poor survival and act as a promising biomarker for individualized therapy for patients with colonic cancer, especially for those diagnosed at an early stage.
|
19236507 |
2009 |
Malignant neoplasm of stomach
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 expression in paraffin-embedded tumor specimens from 293 patients with gastric cancer was studied retrospectively by immunohistochemistry.
|
19322925 |
2009 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
PRL-3 expression in paraffin-embedded tumor specimens from 293 patients with gastric cancer was studied retrospectively by immunohistochemistry.
|
19322925 |
2009 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
PRL-3 is a key gene associated with progression and metastasis of colorectal cancer.
|
19440036 |
2009 |